Abstract
Objectives
The study aimed to predict surgical risks for patients with symptomatic stricturing Crohn’s disease (CD) using computed tomography enterography (CTE) and to assess the association between CTE findings and pathological changes.
Methods
Crohn’s disease patients with symptomatic stricture(s) were included. Exclusion criteria were concomitant penetrating disease, intra-abdominal abscess, previous bowel resection, or asymptomatic. Patients from January 2016 to December 2019 were identified as the primary cohort and those from January 2020 to June 2020 were identified as the validation cohort. Two independent experienced radiologists evaluated CTE variables including mucosal enhancement, mural stratification, wall enhancement, comb sign, lymphadenopathy, thick non-enhancing wall, bowel wall thickness, luminal diameter, and upstream lumen. Receiver operating characteristic, logistic regression, and nomogram were performed to identify the independent predictors of surgical-free survival. Histopathological scores of surgical specimens were also evaluated.
Results
198 patients (primary cohort, 123 with surgery and 75 under non-surgical intervention, and 41 patients (validation cohort) were analyzed. Bowel wall thickness < 5.9 mm, luminal stenosis > 3.35 mm, and upstream lumen < 27.5 mm were predictors of surgical-free survival for symptomatic stricturing CD patients. Logistic analysis showed the three CTE variables were the independent predictors of surgical-free survival (p < 0.001). A nomogram was developed with the concordance indexes of 0.905 and 0.892 in the primary and validation cohorts. Histopathological analysis showed bowel wall muscular hyperplasia/hypertrophy significantly correlated with luminal stenosis (r = − 0.655, p = 0.008) and combined CTE variable (r = − 0.683, p = 0.005).
Conclusions
CTE is highly predictive of disease course and surgical-free survival for patients with symptomatic stricturing CD, suggesting the important role of CTE in decision-making of treatment.
Graphical abstract
Similar content being viewed by others
Abbreviations
- AUC:
-
Area under curve
- CTE:
-
Computed tomography enterography
- C-index:
-
Concordance index
- CI:
-
Confidence interval
- CD:
-
Crohn’s disease
- DCA:
-
Decision curve analysis
- HBI:
-
Harvey–Bradshaw index
- IBD:
-
Inflammatory bowel disease
- PMTS:
-
Possible maximum total score
- ROC:
-
Receiver operating characteristic
References
Rieder F, Bettenworth D, Ma C, et al. An expert consensus to standardise definitions, diagnosis and treatment targets for anti-fibrotic stricture therapies in Crohn's disease. Aliment Pharmacol Ther 2018;48:347-357.
Neurath MF. Current and emerging therapeutic targets for IBD. Nat Rev Gastroenterol Hepatol 2017;14:269-278.
Jairath V, Levesque BG, Vande Casteele N, et al. Evolving Concepts in Phases I and II Drug Development for Crohn's Disease. J Crohns Colitis 2017;11:246-255.
Bossuyt P, Debeuckelaere C, Ferrante M, et al. Risk Stratification for Surgery in Stricturing Ileal Crohn's Disease: The BACARDI Risk Model. J Crohns Colitis 2018;12:32-38.
Allocca M, Fiorino G, Bonifacio C, et al. Noninvasive Multimodal Methods to Differentiate Inflamed vs Fibrotic Strictures in Patients With Croh n's Disease. Clin Gastroenterol Hepatol 2019;17:2397-2415.
Rieder F, Latella G, Magro F, et al. European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of F ibrostenosing Crohn's Disease. J Crohns Colitis 2016;10:873-885.
Bettenworth. D, Bokemeyer. A, Baker. M, et al. Assessment of Crohn’s disease-associated smal bowel strictures and fibrosis on cross-sectional imaging: a systematic review. Gut 2019;68:1115-1126.
Bouhnik Y, Carbonnel F, Laharie D, et al. Efficacy of adalimumab in patients with Crohn's disease and symptomatic small bowel stricture: a multicentre, prospective, observational cohort (CREOLE) study. Gut 2018;67:53-60.
D'Alessio S, Ungaro F, Noviello D, et al. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol 2022;19:169-184.
Wagner M, Ko HM, Chatterji M, et al. Magnetic Resonance Imaging Predicts Histopathological Composition of Ileal Crohn's Disease. J Crohns Colitis 2018;12:718-729.
Chiorean MV, Sandrasegaran K, Saxena R, et al. Correlation of CT enteroclysis with surgical pathology in Crohn's disease. Am J Gastroenterol 2007;102:2541-2550.
Adler J, Punglia DR, Dillman JR, et al. Computed tomography enterography findings correlate with tissue inflammation, not fibrosis in resected small bowel Crohn's disease. Inflamm Bowel Dis 2012;18:849-856.
De Voogd FA, Mookhoek A, Gecse KB, et al. Systematic Review: Histological Scoring of Strictures in Crohn's Disease. J Crohns Colitis 2020;14:734-742.
Chen. W, Lu. C, Hirota. C, et al. Smooth Muscle Hyperplasia/Hypertrophy is the Most Prominent Histological Change in Crohn’s Fibrostenosing Bowel Strictures: A Semiquantitative Analysis by Using a Novel Histological Grading Scheme. Journal of Crohn's and Colitis 2017;11:92-102.
Gomollon F, Dignass A, Annese V, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management. J Crohns Colitis 2017;11:3-25.
Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet 1980;1:514.
Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565-574.
Kastrinos F, Uno H, Ukaegbu C, et al. Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol 2017;35:2165-2172.
Campos C, Perrey A, Lambert C, et al. Medical Therapies for Stricturing Crohn's Disease: Efficacy and Cross-Sectional Imaging Predictors of Therapeutic Failure. Dig Dis Sci 2017;62:1628-1636.
Schulberg JD, Wright EK, Holt BA, et al. Magnetic resonance enterography for predicting the clinical course of Crohn's disease strictures. J Gastroenterol Hepatol 2020;35:980-987.
Bruining DH, Zimmermann EM, Loftus EV, Jr., et al. Consensus Recommendations for Evaluation, Interpretation, and Utilization of Computed Tomography and Magnetic Resonance Enterography in Patients With Small Bowel Crohn's Disease. Gastroenterology 2018;154:1172-1194.
Lu C, Baraty B, Lee Robertson H, et al. Systematic review: medical therapy for fibrostenosing Crohn's disease. Aliment Pharmacol Ther 2020;51:1233-1246.
Cushing K, Higgins PDR. Management of Crohn Disease: A Review. Jama 2021;325:69-80.
Fang ZN, Li XH, Lin JJ, et al. Magnetisation transfer imaging adds information to conventional MRIs to differentiate inflammatory from fibrotic components of small intestinal strictures in Crohn's disease. Eur Radiol 2020;30:1938-1947.
Gordon IO, Bettenworth D, Bokemeyer A, et al. Histopathology Scoring Systems of Stenosis Associated With Small Bowel Crohn's Disease: A Systematic Review. Gastroenterology 2020;158:137-150 e1.
Funding
This study was supported by National Natural Science Foundation of China (Grant 82170573, 81770556, and 81670471).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no competing interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Duan, M., Guan, B., Cao, L. et al. Computed tomography enterography predicts surgical-free survival in symptomatic stricturing Crohn’s disease. Abdom Radiol 47, 3414–3423 (2022). https://doi.org/10.1007/s00261-022-03588-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-022-03588-0